Darius Moradpour
#148,402
Most Influential Person Now
Researcher
Darius Moradpour's AcademicInfluence.com Rankings
Darius Moradpourcomputer-science Degrees
Computer Science
#7631
World Rank
#8034
Historical Rank
Computational Linguistics
#1558
World Rank
#1575
Historical Rank
Machine Learning
#2880
World Rank
#2916
Historical Rank
Artificial Intelligence
#3174
World Rank
#3221
Historical Rank

Download Badge
Computer Science
Darius Moradpour's Degrees
- Masters Artificial Intelligence Stanford University
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Darius Moradpour Influential?
(Suggest an Edit or Addition)Darius Moradpour's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus (2005) (2398)
- EASL Clinical Practice Guidelines: management of chronic hepatitis B. (2009) (1471)
- Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. (2010) (1216)
- Expression of Hepatitis C Virus Proteins Induces Distinct Membrane Alterations Including a Candidate Viral Replication Complex (2002) (943)
- EASL Clinical Practice Guidelines: Wilson's disease. (2012) (747)
- Replication of hepatitis C virus (2007) (710)
- Identification of the Hepatitis C Virus RNA Replication Complex in Huh-7 Cells Harboring Subgenomic Replicons (2003) (696)
- In vivo gene electroinjection and expression in rat liver (1996) (427)
- Structural biology of hepatitis C virus (2004) (415)
- An Amino-terminal Amphipathic α-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5A* (2002) (387)
- Subcellular Localization, Stability, andtrans-Cleavage Competence of the Hepatitis C Virus NS3-NS4A Complex Expressed in Tetracycline-Regulated Cell Lines (2000) (340)
- Structural biology of hepatitis C virus. (2003) (333)
- EASL Clinical Practice Guidelines on hepatitis E virus infection. (2018) (329)
- Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway (1999) (313)
- Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A* (2004) (305)
- Insertion of Green Fluorescent Protein into Nonstructural Protein 5A Allows Direct Visualization of Functional Hepatitis C Virus Replication Complexes (2004) (286)
- Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. (2009) (286)
- Hepatitis C virus proteins: from structure to function. (2013) (283)
- The Native Form and Maturation Process of Hepatitis C Virus Core Protein (1998) (269)
- The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. (2001) (266)
- Characterization of cell lines allowing tightly regulated expression of hepatitis C virus core protein. (1996) (251)
- Determinants for Membrane Association of the Hepatitis C Virus RNA-dependent RNA Polymerase* (2001) (244)
- IL28B expression depends on a novel TT/-G polymorphism which improves HCV clearance prediction (2013) (214)
- Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway (2001) (206)
- Structural and Functional Studies of Nonstructural Protein 2 of the Hepatitis C Virus Reveal Its Key Role as Organizer of Virion Assembly (2010) (202)
- Expression of hepatitis c virus proteins inhibits interferon alpha signaling in the liver of transgenic mice. (2003) (190)
- [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection]. (2018) (185)
- Membrane Association of the RNA-Dependent RNA Polymerase Is Essential for Hepatitis C Virus RNA Replication (2004) (181)
- Pathogenesis of hepatocellular carcinoma. (2005) (177)
- NS2 Protein of Hepatitis C Virus Interacts with Structural and Non-Structural Proteins towards Virus Assembly (2011) (177)
- Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin. (2016) (168)
- Update on hepatitis E virology: Implications for clinical practice. (2016) (168)
- [Management of chronic hepatitis B]. (2010) (167)
- Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins (1998) (163)
- Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex. (2003) (162)
- Interaction of hepatitis C virus proteins with host cell membranes and lipids. (2002) (159)
- Nonstructural protein 3‐4A: the Swiss army knife of hepatitis C virus (2011) (158)
- Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference (2009) (158)
- Hepatitis C Virus Glycoprotein Complex Localization in the Endoplasmic Reticulum Involves a Determinant for Retention and Not Retrieval* (1998) (158)
- Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. (2012) (155)
- IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non‐1 HCV genotypes (2012) (153)
- euHCVdb: the European hepatitis C virus database (2006) (149)
- Hepatitis C Virus-Linked Mitochondrial Dysfunction Promotes Hypoxia-Inducible Factor 1α-Mediated Glycolytic Adaptation (2009) (147)
- A Dynamic View of Hepatitis C Virus Replication Complexes (2008) (146)
- Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex (2008) (138)
- Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon‐sensitive virus replication (1999) (137)
- Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis (2000) (136)
- NS4B Self-Interaction through Conserved C-Terminal Elements Is Required for the Establishment of Functional Hepatitis C Virus Replication Complexes (2011) (136)
- Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV, Switzerland (2011) (131)
- Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection. (2011) (126)
- Cleavage of mitochondrial antiviral signaling protein in the liver of patients with chronic hepatitis C correlates with a reduced activation of the endogenous interferon system (2010) (124)
- Hepatitis C virus protein expression causes calcium‐mediated mitochondrial bioenergetic dysfunction and nitro‐oxidative stress (2007) (124)
- Hepatitis C virus nonstructural protein 4B: a journey into unexplored territory (2010) (124)
- Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes (2014) (123)
- [Molecular virology of hepatitis C]. (2002) (122)
- Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
- The Hepatitis C Virus RNA-Dependent RNA Polymerase Membrane Insertion Sequence Is a Transmembrane Segment (2002) (117)
- Viral genotype-specific role of PNPLA3, PPARG, MTTP, and IL28B in hepatitis C virus-associated steatosis. (2011) (114)
- Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5). (2016) (110)
- Chlorpromazine‐induced vanishing bile duct syndrome leading to biliary cirrhosis (1994) (110)
- GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer (2014) (108)
- Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway. (2001) (105)
- Hepatitis E Virus Seroprevalence among Blood Donors in Southwest Switzerland (2011) (103)
- Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B (2009) (98)
- Impact of common risk factors of fibrosis progression in chronic hepatitis C (2014) (96)
- Expression and immune response to hepatitis C virus core DNA–based vaccine constructs (1996) (95)
- Molecular Virology of Hepatitis C Virus (HCV): 2006 Update (2006) (92)
- Upregulation of Protein Phosphatase 2Ac by Hepatitis C Virus Modulates NS3 Helicase Activity through Inhibition of Protein Arginine Methyltransferase 1 (2005) (92)
- Amphipathic α-Helix AH2 Is a Major Determinant for the Oligomerization of Hepatitis C Virus Nonstructural Protein 4B (2010) (84)
- Acromegaly caused by secretion of growth hormone by a non-Hodgkin's lymphoma. (2000) (82)
- Hepatitis delta-associated mortality in HIV/HBV-coinfected patients. (2017) (80)
- Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study (2018) (78)
- Hepatitis C Virus Infection and Kidney Transplantation in 2014: What's New? (2014) (77)
- An Amphipathic α-Helix at the C Terminus of Hepatitis C Virus Nonstructural Protein 4B Mediates Membrane Association (2009) (75)
- Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. (2013) (75)
- Gene therapy for chronic viral hepatitis: Ribozymes, antisense oligonucleotides, and dominant negative mutants (1997) (72)
- Liver‐directed gene transfer: a linear polyethylenimine derivative mediates highly efficient DNA delivery to primary hepatocytes in vitro and in vivo (1998) (70)
- Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: a systematic review and meta-analysis of controlled trials (2015) (69)
- Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index (2014) (69)
- Clinical phenotype and outcome of hepatitis E virus–associated neuralgic amyotrophy (2017) (64)
- HCV infection induces mitochondrial bioenergetic unbalance: causes and effects. (2009) (63)
- Genetic Analyses Reveal a Role for Vitamin D Insufficiency in HCV-Associated Hepatocellular Carcinoma Development (2013) (62)
- A Genetic Validation Study Reveals a Role of Vitamin D Metabolism in the Response to Interferon-Alfa-Based Therapy of Chronic Hepatitis C (2012) (62)
- Hepatitis C virus infection in haemodialysis and kidney transplant patients (2008) (61)
- Cytotoxic T Lymphocytes Derived from Patients with Chronic Hepatitis C Virus Infection Kill Bystander Cells via Fas-FasL Interaction (2004) (61)
- [DNA vaccination]. (2000) (60)
- Correction: Corrigendum: Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes (2014) (59)
- Hepatitis C: molecular virology and antiviral targets. (2002) (58)
- Characterization of three novel monoclonal antibodies against hepatitis C virus core protein (1996) (57)
- Functional Properties of a Monoclonal Antibody Inhibiting the Hepatitis C Virus RNA-dependent RNA Polymerase* (2002) (56)
- An Analysis of the Benefit of Using HEV Genotype 3 Antigens in Detecting Anti-HEV IgG in a European Population (2013) (55)
- NMR structure and molecular dynamics of the in-plane membrane anchor of nonstructural protein 5A from bovine viral diarrhea virus. (2006) (54)
- The cyclophilin inhibitor alisporivir prevents hepatitis C virus–mediated mitochondrial dysfunction (2012) (52)
- Vitamin D Receptor and Jak–STAT Signaling Crosstalk Results in Calcitriol-Mediated Increase of Hepatocellular Response to IFN-α (2014) (51)
- A liposomal peptide vaccine inducing CD8+ T cells in HLA-A2.1 transgenic mice, which recognise human cells encoding hepatitis C virus (HCV) proteins. (2004) (50)
- Palmitoylation mediates membrane association of hepatitis E virus ORF3 protein and is required for infectious particle secretion (2018) (50)
- Understanding hepatitis B virus infection. (1995) (49)
- Tuberculous colitis mimicking Crohn's disease (1998) (49)
- Aminoterminal Amphipathic α-Helix AH1 of Hepatitis C Virus Nonstructural Protein 4B Possesses a Dual Role in RNA Replication and Virus Production (2014) (49)
- Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B (2013) (47)
- Serum ferritin levels are associated with a distinct phenotype of chronic hepatitis C poorly responding to pegylated interferon‐alpha and ribavirin therapy (2012) (47)
- Viral pathogenesis of hepatocellular carcinoma (2002) (47)
- Function follows form: The structure of the N‐terminal domain of HCV NS5A (2005) (47)
- Efficient gene transfer into mammalian cells with cholesteryl-spermidine. (1996) (45)
- Systematic review with meta‐analysis: self‐expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding (2015) (45)
- Visualization of hepatitis E virus RNA and proteins in the human liver. (2017) (45)
- Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up (2017) (44)
- Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland. (2019) (44)
- Current and evolving therapies for hepatitis C. (1999) (42)
- [Eosinophilic gastrointestinal disorders]. (2016) (42)
- Conserved Determinants for Membrane Association of Nonstructural Protein 5A fromHepatitis C Virus and Related Viruses (2006) (41)
- Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis (2020) (40)
- [DNA chip technology]. (1999) (40)
- Quantitative proteomics identifies the membrane‐associated peroxidase GPx8 as a cellular substrate of the hepatitis C virus NS3‐4A protease (2014) (40)
- Tightly regulated expression of the entire hepatitis C virus structural region in continuous human cell lines. (1998) (40)
- Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibody−based gene delivery system (1999) (39)
- Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems. (2017) (36)
- Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus. (2008) (36)
- Prevalence of anti‐HLA antibodies after liver transplantation (2009) (35)
- Comparison between cytomegalovirus promoter and elongation factor-1 alpha promoter-driven constructs in the establishment of cell lines expressing hepatitis C virus core protein. (1997) (35)
- Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection. (2013) (35)
- Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro (2001) (34)
- A systematic review and meta‐analysis of HCV clearance (2017) (32)
- Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro (1995) (31)
- A primer on the molecular virology of hepatitis C (2004) (31)
- Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression (1999) (27)
- Recombinant Hepatitis E Viruses Harboring Tags in the ORF1 Protein (2019) (26)
- Targeting mitochondria in the infection strategy of the hepatitis C virus. (2013) (26)
- Future landscape of hepatitis C research - Basic, translational and clinical perspectives. (2016) (25)
- Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5 A (2004) (25)
- A European survey of perendoscopic treatment of biliary complications in patients with alveolar echinococcosis (2017) (25)
- Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion (2020) (25)
- Neurologic complications of acute hepatitis E virus infection (2019) (24)
- Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus (2016) (24)
- Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication (2017) (23)
- Multiplex Liquid Chromatography-Tandem Mass Spectrometry Assay for Simultaneous Therapeutic Drug Monitoring of Ribavirin, Boceprevir, and Telaprevir (2013) (23)
- GLUT3 is induced during epithelial-mesenchymal transition and promotes tumor cell proliferation in non-small cell lung cancer (2014) (23)
- Hepatitis E virus as a cause of acute hepatitis acquired in Switzerland (2017) (23)
- [An update on the management of chronic hepatitis C]. (2010) (22)
- Identification of Naturally Processed Hepatitis C Virus-Derived Major Histocompatibility Complex Class I Ligands (2012) (22)
- Wheat germ cell-free expression: Two detergents with a low critical micelle concentration allow for production of soluble HCV membrane proteins. (2015) (22)
- Hepatitis E virus infection as a direct cause of neuralgic amyotrophy (2016) (22)
- Hepatitis C virus infection: in vivo and in vitro models (2007) (21)
- Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania. (2016) (20)
- Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis. (2014) (20)
- The molecular pathogenesis of hepatocellular carcinoma (1994) (19)
- Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins (1998) (19)
- Hepatitis C Virus RNA Replication Requires a Conserved Structural Motif within the Transmembrane Domain of the NS5B RNA-Dependent RNA Polymerase (2010) (19)
- Sofosbuvir add-on to ribavirin for chronic hepatitis E in a cirrhotic liver transplant recipient: a case report (2019) (18)
- New insights into hepatitis B and C virus co-infection. (2009) (18)
- Immunosuppression in hepatitis C virus-infected patients after kidney transplantation. (2012) (17)
- Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study (2017) (17)
- Elderly age is not a negative predictive factor for virological response to therapy with pegylated interferon‐α and ribavirin in chronic hepatitis C virus patients (2014) (17)
- Determinants for Membrane Association of the Hepatitis C Virus NS2 Protease Domain (2014) (17)
- Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. (2012) (16)
- Hepatitis C update (2001) (16)
- Human transmissible spongiform encephalopathies. (1998) (16)
- Acute immune thrombocytopaenic purpura in a patient with COVID-19 and decompensated cirrhosis (2020) (16)
- Immunological approach to hepatocellular carcinoma (1997) (16)
- Effect of antiviral therapy on circulating cytokeratin‐18 fragments in patients with chronic hepatitis C (2010) (16)
- Genomic determinants of the efficiency of internal ribosomal entry sites of viral and cellular origin (2008) (15)
- Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infection (2012) (15)
- Impact of genetic SLC28 transporter and ITPA variants on ribavirin serum level, hemoglobin drop and therapeutic response in patients with HCV infection (2012) (15)
- Targeting Endoplasmic Reticulum and/or Mitochondrial Ca2+ Fluxes as Therapeutic Strategy for HCV Infection (2018) (14)
- An Aminoterminal Amphipathic-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5 A (2001) (14)
- Trends in hepatitis C‐related mortality in Switzerland (2018) (14)
- Protective role of amantadine in mitochondrial dysfunction and oxidative stress mediated by hepatitis C virus protein expression. (2014) (14)
- A fresh look at interferon‐α signaling and treatment outcomes in chronic hepatitis C (2008) (13)
- Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? (2019) (13)
- [Therapy of chronic hepatitis C]. (2006) (13)
- Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing? (2019) (13)
- Characterization of Nonstructural Protein Membrane Anchor Deletion Mutants Expressed in the Context of the Hepatitis C Virus Polyprotein (2005) (13)
- Biomarkers of liver dysfunction correlate with a prothrombotic and not with a prohaemorrhagic profile in patients with cirrhosis (2020) (13)
- Glycogen Synthase Kinase 3β Enhances Hepatitis C Virus Replication by Supporting miR-122 (2018) (12)
- Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections. (2019) (12)
- On the Host Side of the Hepatitis E Virus Life Cycle (2020) (12)
- Enhanced Gene Delivery and Expression in Human Hepatocellular Carcinoma Cells by Cationic Immunoliposomes (1997) (12)
- Therapie der chronischen Hepatitis C (2005) (12)
- The histologic presentation of hepatitis E reflects patients’ immune status and pre-existing liver condition (2020) (11)
- Autoimmune liver serology before and after successful treatment of chronic hepatitis C by direct acting antiviral agents. (2019) (11)
- BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease (2016) (11)
- Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-β induction by efficient MAVS cleavage. (2015) (11)
- Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis (2020) (11)
- Injection drug use before and after liver transplantation: a retrospective multicenter analysis on incidence and outcome (2010) (10)
- Resistance‐associated substitutions in patients with chronic hepatitis C virus genotype 4 infection (2020) (10)
- NS2 Proteins of GB Virus B and Hepatitis C Virus Share Common Protease Activities and Membrane Topologies (2014) (10)
- Late hepatitis B reactivation following direct‐acting antiviral–based treatment of recurrent hepatitis C in an anti‐HBc–positive liver transplant recipient (2018) (10)
- the Swiss Hepatitis C Cohort Study Group (2011) (9)
- Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations (2016) (9)
- Investigation of the hepatitis C virus replication complex. (2009) (8)
- Independent regulation of two separate gene activities in a continuous human cell line. (1998) (8)
- Therapeutic drug monitoring for sofosbuvir and daclatasvir in transplant recipients with chronic hepatitis C and advanced renal disease. (2016) (8)
- Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir. (2012) (8)
- Review article: HCV ? STAT-C era of therapy (2010) (8)
- Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre. (2018) (8)
- Differential modulation of hepatitis C virus replication and innate immune pathways by synthetic calcitriol-analogs (2018) (8)
- Combined Lung and Liver Transplantation for Short Telomere Syndrome (2020) (7)
- Management of Severe Portopulmonary Hypertension With Dual Oral Therapy Before Liver Transplantation. (2018) (7)
- Hepatitis C virus comes full circle: Production of recombinant infectious virus in tissue culture (2005) (7)
- Clinical Significance of the CCR5delta32 Allele in Hepatitis C (2014) (7)
- [Hepatitis C: epidemiology natural course and diagnosis]. (2015) (7)
- Ligand-mediated retargeting of recombinant adenovirus for gene transfer in vivo (2000) (7)
- Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management (2021) (7)
- LP54 : Sofosbuvir inhibits hepatitis E virus replication in vitro and results in an additive effect when combined with ribavirin (2015) (7)
- [Hepatitis B virus mutants--clinical significance]. (1997) (7)
- Recent developments in target identification against hepatitis C virus (2004) (7)
- A model for the study of hepatitis C virus entry (2003) (6)
- [Diagnosis of hepatitis B and C]. (2005) (6)
- Combined antiviral therapy for recurrent hepatitis C virus after liver transplantation. (2007) (6)
- Optimizing Ribavirin Exposure by Therapeutic Drug Monitoring Improves Treatment Response in Patients With Chronic Hepatitis C Genotype 1 (2013) (6)
- Treatment of chronic hepatitis E with ribavirin: lessons from deep sequencing (2016) (6)
- CLINICAL ADVANCES IN LIVER, PANCREAS, AND BILIARY TRACT Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study (2010) (5)
- Of mice and men: A small animal model of hepatitis C virus replication (2002) (5)
- Reading between the lines: Evidence for a new hepatitis C virus protein (2002) (5)
- Oral valganciclovir for cytomegalovirus colitis after liver transplantation. (2007) (5)
- Surprises from the crystal structure of the hepatitis C virus NS2‐3 protease (2006) (5)
- [Management of chronic viral hepatitis]. (2007) (5)
- Access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study: a person‐centred approach (2016) (5)
- Stable human lymphoblastoid cell lines constitutively expressing hepatitis C virus proteins. (2005) (5)
- Hepatitis C: a concise review. (2001) (4)
- Lower Risk of B1-to-pB3-Stage Migration in Crohn’s Disease Upon Immunosuppressive and Anti-TNF Treatment in the Swiss IBD Cohort Study (2019) (4)
- Progress in Understanding the Pathogenesis of Nonalcoholic Fatty Liver Disease (2004) (4)
- Hepatitis B und C: von der molekularen Virologie zu neuen Perspektiven in der Therapie (2014) (4)
- Hepatitis E virus finds its path through the gut (2020) (4)
- Human genomics of acute liver failure due to hepatitis B virus infection: an exome sequencing study in liver transplant recipients (2018) (4)
- OCIAD1 is a host mitochondrial substrate of the hepatitis C virus NS3-4A protease (2020) (4)
- Cell lines that allow regulated expression of HCV proteins: principles and applications (2003) (4)
- 544 A EUROPEAN FIELD STUDY OF THE EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) AS MONOTHERAPY IN PATIENTS WITH PRIOR FAILURE TO OTHER NUCLEOSIDE/NUCLEOTIDE ANALOGUES (2012) (4)
- Chapter 8 – Replication and Pathogenesis of Hepatitis C Virus (2006) (4)
- Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction (2022) (4)
- [New hepatitis C treatments: pharmacological considerations and potential for drug interactions]. (2014) (4)
- Trends in hepatitis C-related mortality in Switzerland (2017) (4)
- [Outpatient follow-up of liver transplant recipients: the essential role of the general practitioner]. (2019) (4)
- Hepatitis E virus RNA‐dependent RNA polymerase is involved in RNA replication and infectious particle production (2021) (3)
- All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS) (2020) (3)
- Consequences of the multipatient use of a single-patient capillary blood sampling device (CBSD) (2011) (3)
- NATURAL COURSE OF HBV INFECTION (1998) (3)
- [Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]. (2014) (3)
- 1401 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES VARIANTS ASSOCIATED WITH LIVER FIBROSIS PROGRESSION IN HCV-INFECTED PATIENTS (2012) (3)
- Uncontrolled hepatitis delta virus infection after initial suppression on tenofovir in a HIV/HBV-coinfected patient. (2016) (3)
- [An update on hepatitis E]. (2013) (3)
- Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events (2022) (3)
- Successful heart and liver transplantation in a Swiss patient with Glu89Lys transthyretin amyloidosis. (2011) (3)
- [Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. (2014) (3)
- BRIP 1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV-or HBV-related liver disease (2019) (3)
- Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center (2021) (3)
- Hepatology highlights: Viral hepatitis (2004) (3)
- [Disseminated toxoplasmosis in AIDS]. (1993) (3)
- Disseminierte Toxoplasmose bei AIDS (2008) (3)
- Clinical phenotype and outcome of hepatitis E virus associated neuralgic amyotrophy; an international retrospective comparative cohort study (2017) (3)
- 1361 IL28B POLYMORPHISMS LINKED TO POOR RESPONSE TO TREATMENT ARE ASSOCIATED WITH LOW NECROINFLAMMATORY ACTIVITY AND SLOW FIBROSIS PROGRESSION IN HCV GENOTYPE NON-1-INFECTED PATIENTS (2011) (3)
- A new twist to translation initiation of the hepatitis C virus (2002) (3)
- [Clinical significance of hepatitis B virus mutants]. (1998) (3)
- Rapid Remission of Graves' Hyperthyroidism Without Thionamides Under Immunosuppressive Treatment for Concomitant Autoimmune Hepatitis. (2018) (2)
- Chasing the escape mutant (1993) (2)
- [Liver transplantation: new organ allocation system in Switzerland]. (2008) (2)
- Hepatitis C: aktuelle Therapie (2015) (2)
- DIE PRIMAR-SKLEROSIERENDE CHOLANGITIS (2008) (2)
- The promise of advanced imaging techniques for the detection of hepatitis C virus antigens in the infected liver. (2009) (2)
- Hepatitis C virus proteins promote mitochondrial bioenergetic dysfunction and nitro-oxidative stress: insights into pathogenesis (2009) (2)
- 75: A variant of IFNλ4 displaying decreased activity is associated with better hepatitis C virus clearance and reduced ISG expression (2014) (2)
- Sofosbuvir and ribavirin before liver re-transplantation for graft failure due to recurrent hepatitis C: a case report (2015) (2)
- Effect of hepatitis B virus on steatosis in hepatitis C virus co‐infected subjects: A multi‐centre study and systematic review (2018) (2)
- Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study (2019) (2)
- A mouse model for hepatitis E virus infection. (2016) (2)
- Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis (2021) (2)
- [Nosebleed, vision disorders]. (1990) (2)
- Le point sur le traitement de l'hépatite C chronique [An update on the management of chronic hepatitis C] (2010) (2)
- [Complications of liver cirrhosis: oesophageal varices, ascites and hepato-cellular carcinoma]. (2005) (2)
- Antisense oligonucleotide therapy of hepadnavirus infection. (2000) (1)
- Treatment of Chronic Hepatitis C (2015) (1)
- [Hepatitis C, diagnosis and therapy]. (1996) (1)
- 1419 IL28B RNA EXPRESSION DEPENDS ON A NOVEL TT/-G POLYMORPHISM ASSOCIATED WITH IMPROVED HCV CLEARANCE PREDICTION (2013) (1)
- High-dimensional immune phenotyping of blood cells by mass cytometry in patients infected with hepatitis C virus. (2021) (1)
- Antiviral treatment of patients with HBV‐related cirrhosis (2002) (1)
- [Advances in gastroenterology and hepatology 2020]. (2021) (1)
- Hepatitis G virus infection in Chinese patients with chronic hepatitis B, C or non-A-E: clinical and molecular aspects (1999) (1)
- Impact of tenofovir on hepatitis delta virus replication in the Swiss HIV Cohort Study (2017) (1)
- [Early TIPS: a practical review after 15 years of scientific evidence]. (2020) (1)
- Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. (2022) (1)
- [Highlights in hepatology]. (2009) (1)
- [Management of ascites due to portal hypertension]. (2012) (1)
- [Molecular aspects of hepatocellular carcinoma]. (2000) (1)
- P0683 : Hepatitis C virus NS3-4A protease targets the host factor BNIP1 at a non-canonical cleavage site (2015) (1)
- Palmitoylation determines the subcellular localization of the hepatitis E virus ORF3 protein (2018) (1)
- P701 AUTOCHTHONOUS ACUTE HEPATITIS E IN SWITZERLAND: INCREASED RATE OF SEVERE MANIFESTATION IN MEN >50 YEARS (2014) (1)
- Hepatitis B und C: von der molekularen Virologie zu neuen Perspektiven in der Therapie (2014) (1)
- Hépatitis C. Therapeutische Fortschritte (2012) (1)
- Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C (2021) (1)
- Hepatitis C: Epidemiologie, natürlicher Verlauf und Diagnostik (2015) (1)
- Diagnostik der Hepatitis B und C (2005) (1)
- [Management of hepatocellular carcinoma]. (2010) (1)
- [Visceral leishmaniasis as an opportunistic infection. Case report and literature review]. (1990) (1)
- 1357 A LARGE-SCALE GENETIC VALIDATION STUDY COUPLED WITH IN-VITRO ANALYSES REVEAL A ROLE OF VITAMIN D-SIGNALING IN THE PATHOGENESIS AND TREATMENT OF CHRONIC HEPATITIS C (2011) (1)
- TEMPORARY REMOVAL: Hepatitis A and E - differences and commonalities. (2020) (1)
- [Primary biliary cholangitis : an update]. (2018) (1)
- [Hepatitis C: current therapy]. (2015) (1)
- Cholestase: Definition, Differentialdiagnose und laborchemische Diagnostik (1999) (1)
- [Lipid-lowering treatment and liver dysfunction]. (2012) (1)
- Structure and function of the membrane domain of hepatitis C virus nonstructural protein 5A (2004) (1)
- [Auto-immune liver diseases and their treatment]. (2005) (1)
- Sa1262 Long Diagnostic Delay in Crohn's Disease is Associated With Complicated Disease Course and Increased Operation Rate (2012) (1)
- Sa1230 Frequency and Type of Side Effects of Immunomodulating Medication in the Swiss Inflammatory Bowel Disease Cohort (2012) (1)
- Hypothyroidism, Congenital (2005) (1)
- Identification of glycogen synthase kinase 3 beta as a novel host factor of hepatitis C virus replication (2017) (0)
- [Progress and new challenges in hepatitis C]. (2013) (0)
- Increasing prevalence of obesity and diabetes among patients evaluated for liver transplantation in a Swiss tertiary referral center: a 10-year retrospective analysis. (2022) (0)
- Treatment of Chronic Hepatitis C - August 2017 Update (2017) (0)
- [Highlights in gastroenterology and hepatology 2010]. (2011) (0)
- 123 A FUNCTIONAL LINK BETWEEN VITAMIN D RECEPTOR AND JAK-STAT SIGNALING RESULTS IN SYNERGISTIC HEPATOCELLULAR RESPONSE TO CALCITRIOL AND INTERFERON-α (2012) (0)
- [New hepatitis viruses. Molecular biology and clinical aspects]. (1996) (0)
- S12.13 Hepatitis C virus proteins cause calcium-mediated mitochondrial dysfunction and hif-linked bioenergetic compensatory adaptation (2008) (0)
- [SARS-CoV-2 infection and solid organ transplantation]. (2020) (0)
- 417 EFFECT OF ANTIVIRAL THERAPY ON THE CIRCULATING LEVELS OF CYTOKERATIN-18 FRAGMENTS IN CHRONIC HEPATITIS C (2009) (0)
- P0534 : Hepatitis E virus RNA replication is ensured by unprocessed ORF1 protein (2015) (0)
- SARS-CoV-2 infection and solid organ transplantation/ Infection a SARS-CoV-2 et transplantation dorganes solides (2020) (0)
- Short Communication Suppression of short interfering RNA-mediated gene silencing by the structural proteins of hepatitis C virus (2008) (0)
- [Treatment of hepatitis: new ways, new hopes and new challenges]. (2007) (0)
- Hepatitis c virus infection induces pro- and antiapoptotic cell response: who is the winner? (2010) (0)
- Specific inhibition of hepatitis C virus gene expression by antisense oligonucleotides in a tightly regulated cell culture system (1995) (0)
- Tu1172 Primary Sclerosing Cholangitis in the Swiss IBD Cohort Study: Prevalence, Patient Characteristics, and Disease Course (2013) (0)
- [Molecular biology in internal medicine. Report of the 24th Ludwig Heilmeyer Symposium of the Society for Progress in Internal Medicine]. (1997) (0)
- 792 HBV-HCV COINFECTION: A NOVEL MODEL SYSTEM REVEALS INSIGHTS INTO IMMUNOLOGICAL MECHANISMS OF VIRAL INTERFERENCE (2012) (0)
- Screening for Hepatitis C Virus (HCV) protein interactions by the use of intergenotypic replicon chimeras (2011) (0)
- [Short telomere syndrome in adults: a rare entity that should be evoked]. (2022) (0)
- DNA Chip-Technologie (2008) (0)
- [The era of management of hepatitis c patients]. (2011) (0)
- The personality traits activity, self-reproach, and negative affect jointly predict clinical recurrence, depressive symptoms, and low quality of life in inflammatory bowel disease patients (2022) (0)
- Histopathology of hepatitis E is associated with patients’ immune status and preexisting liver condition (2020) (0)
- Strategies for Targeted Uptake of Antisense Oligonucleotides in Hepatocytes (1999) (0)
- P660 THE EFFECT OH HEPATITIS B VIRUS INFECTION ON STEATOSIS IN HEPATITIS C VIRUS COINFECTED PATIENTS: THE BOSTIC STUDY (2014) (0)
- [Hepatitis C: 25 years of progress with still major challenges]. (2015) (0)
- Mechanisms of Interferon Resistance (2007) (0)
- [Implication of mutation of hepatitis C virus 1b interferon sensitivity determining region(NS5A aa 2209-2248) response to interferon alpha therapy in patients with chronic hepatitis C]. (1999) (0)
- 802 CHARACTERIZATION OF A MAJOR V3 DUPLICATION IN THE NS5A REGION OF GENOTYPE IB HCV BY QUASISPECIES ANALYSIS IN A FRENCH MULTICENTER STUDY (2011) (0)
- [Fecal calprotectin: a diagnostic tool for inflammatory bowel disease]. (2012) (0)
- Recombinant drugs and gene therapy (1999) (0)
- A genome-wide CRISPR/Cas9 screen identifies Rab5A as host factor of the hepatitis E virus life cycle (2022) (0)
- [Coffee and the pancreas: a half life of medical truth]. (2014) (0)
- [Maculopapular rash, pruritus, upper abdominal pain, attacks of dizziness]. (1991) (0)
- [Transthyretin-related hereditary amyloidosis]. (2016) (0)
- P0200 : Early transjugular intrahepatic portosystemic shunt in cirrhotic patients with acute variceal bleeding: A meta-analysis of controlled trials (2015) (0)
- Hepatitis-B-Virusmutanten--klinische Bedeutung. [Hepatitis B virus mutants--clinical significance] (1997) (0)
- Chronic hepatitis C: Portrait of a silent epidemic and the etiologic agent (2008) (0)
- Amphipathic (cid:1) -Helix AH2 Is a Major Determinant for the Oligomerization of Hepatitis C Virus Nonstructural Protein 4B (cid:1) † (2010) (0)
- Hépatite C: information pour les patients (2015) (0)
- Effect of Hepatitis B virus on Steatosis in Hepatitis C virus co-infected subjects: a multi-center study and systematic review (0)
- La transplantation hépatique (2011) (0)
- [Gene technology drugs and gene therapy]. (1999) (0)
- Expanding the Hepatitis E Virus Toolbox: Selectable Replicons and Recombinant Reporter Genomes (2023) (0)
- [Hepatic encephalopathy: recent developments]. (2014) (0)
- P196 INVESTIGATION OF HEPATITIS C VIRUS ADAPTATION TO HOST GENETIC POLYMORPHISMS (2014) (0)
- [Painful knee, fever]. (1987) (0)
- [Hepatocellular adenoma: update 2020]. (2020) (0)
- [Recent progress in hepatology]. (2011) (0)
- Edinburgh Research Explorer Novel Approach Identifies SNPs in SLC2A10 and KCNK9 with Evidence for Parent-of-Origin Effect on Body Mass Index (2017) (0)
- Infection à SARS-CoV-2 et transplantation d’organes solides (2020) (0)
- La transpantation hépatique. (2011) (0)
- SAT-199-Recombinant hepatitis E viruses harbouring tags in the ORF1 protein allow visualisation of the viral replicase (2019) (0)
- University of Groningen Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index Hoggart, (2014) (0)
- Evaluating the individual risk of venous thrombo-embolism in patients with liver cirrhosis: Usefulness of in vivo and ex vivo thrombin generation parameters (2023) (0)
- Primary sclerosing cholangitis in the Swiss In fl ammatory Bowel Disease Cohort Study : prevalence , risk factors , and long-term follow-up (0)
- [Hepatocellular carcinoma: a multidisciplinary approach]. (2005) (0)
- Chapter 7 – Replication of Hepatitis C Virus (2012) (0)
- [A primer on Wilson disease for the general practitioner]. (2011) (0)
- Of mice and men - ein In-vivo-Modell der Hepatitis-C-Virus-Replikation (2002) (0)
- Chronic hepatitis C: portrait of a silent epidemic. (2008) (0)
- NMR structure of the in-plane membrane anchor domain [1-28] of the monotopic NonStructural Protein 5A (NS5A) from the Bovine Viral Diarrhea Virus (BVDV) (2005) (0)
- Expression and immune response to hepatitis C virus DNA vaccine constructs (1995) (0)
- [Alagille Syndrome]. (2019) (0)
- Biochemical Characterization of Hepatitis E Virus ORF3 Protein Student (2016) (0)
- [Hepatitis C: patient information]. (2015) (0)
- S1 Raw images (2020) (0)
- Cell-free expression, purification, and membrane reconstitution for NMR studies of the nonstructural protein 4B from hepatitis C virus (2016) (0)
- HEV as a cause of acute hepatitis acquired in Switzerland (2017) (0)
- 86th annual congress of the Swiss Society of Pathology (2020) (0)
- Determinants for Membrane Association of the HCV NS2 Protease Domain (2012) (0)
- [Chronic hepatitis. 2: Treatment]. (2001) (0)
- Age Above 60 Years Is Not a Negative Predictive Factor For Combined Antiviral Therapy With Pegylated Interferon Alpha and Ribavirin in Hepatitis C Patients (2012) (0)
- The Membrane Anchor of GB virus B Nonstructural Protein 5B Can Substitute the Hepatitis C Virus NS5B Transmembrane Domain: Implications for a Conserved Protein Interaction Site (2010) (0)
- Next-generation sequencing of Swiss HEV isolates allows for reconstitution of functional clones (2022) (0)
- [Primary sclerosing cholangitis]. (1991) (0)
- [Gene technology]. (1999) (0)
- Sarcopenia assessed via computed tomography is associated with short-term outcomes and improves prognostic scores’ performance in critically ill patients with acute on chronic liver failure (2022) (0)
- Structure and Function of the Membrane Anchor Domain of Hepatitis C Virus Nonstructural Protein 5A*□S (2004) (0)
- [When and how to treat hepatitis B and C?]. (2005) (0)
- [A primer on the management of antiviral resistance in chronic hepatitis B]. (2009) (0)
- Hepatitis E Virus ORF3 Protein Forms Membrane-Associated Oligomers (2016) (0)
- Efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis at high thrombotic risk (2021) (0)
- [Alcoholic liver disease: another neglected disease?]. (2012) (0)
- [Metabolism and therapeutic monitoring of azathioprine in gastroenterology and hepatology]. (2022) (0)
- Reexamining the Role of the Humoral Immune Response in Control of Hepatitis C Virus Infection (2004) (0)
- Case Report: SARS-CoV-2 as an unexpected causal agent of isolated febrile hepatitis (2021) (0)
- Continuous human cell lines inducibly expressing the complete hepatitis C virus open reading frame (1997) (0)
- Autochthonous hepatitis E as a cause of acute-on-chronic liver failure and death: histopathology can be misleading but transaminases may provide a clue. (2021) (0)
- All-cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (2019) (0)
- Leonardo Complex Including a Candidate Viral Replication Induces Distinct Membrane Alterations Expression of Hepatitis C Virus Proteins (2002) (0)
- In vitro efficacy of direct oral anticoagulants in plasma from patients with liver cirrhosis (2023) (0)
- NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Minimized average structure, Sample in 100mM DPC) (2004) (0)
- Hepatitis E Virus Seroprevalence and Chronic Infections in Patients with HIV , Switzerland KENFAK-FOGUENA (2019) (0)
- [Dolly, Polly et al.: cloning by somatic cell nucleus transfer]. (1999) (0)
- Cytokines and hepatitis C virus replication (2002) (0)
- Inhibition of interferon alpha signalling through the JAK-STAT pathway in HCV transgenic mice (2001) (0)
- P1309 HCV MUTANTS RESISTANT TO MACROCYCLIC NS3-4A PROTEASE INHIBITORS SUPPRESS INTERFERON-β INDUCTION BY EFFICIENT MAVS CLEAVAGE (2014) (0)
- Specific inhibition of hepatitis C virus core antigen production by antisene RNA constructions (1995) (0)
- 381 Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes in living cells (2003) (0)
- [Liver transplantation]. (2011) (0)
- [Molecular models of disease. Transgenes and knockout]. (1997) (0)
- N-terminal amphipathic alpha-helix 42-66 (AH2) plays a central role in the oligomerization of hepatitis C virus nonstructural protein 4B (2010) (0)
- Chapter 10 – Molecular Pathogenesis of Hepatocellular Carcinoma (2006) (0)
- Molekulare Krankheitsmodelle. Transgene und "knockout". [Molecular models of disease. Transgenes and knockout] (1997) (0)
- Influence of geographical origin on access to therapy and therapy outcomes in hepatitis C virus-infected persons: the Swiss Hepatitis C Cohort Study (2018) (0)
- Syndrome d’Alagille [Alagille Syndrome] (2019) (0)
- [Therapy of hepatitis C]. (2002) (0)
- P168 Primary sclerosing cholangitis in the Swiss IBD cohort study: prevalence, patient characteristics, and disease course (2013) (0)
- [From Molecuar to Natural Medicine]. (2018) (0)
- [Highlights in hepatology]. (2008) (0)
- Body composition and short-term mortality in critically ill patients with acute on chronic liver failure (2023) (0)
- [Hepatitis D: forgotten but not gone]. (2010) (0)
- [New methods for demonstrating nucleic acids]. (2001) (0)
- SAT-207-Rabbit HEV in immunosuppressed patients with hepatitis E acquired in Switzerland (2019) (0)
- Tournament Sessions (2017) (0)
- [Hepatitis C at a crossroads]. (2010) (0)
- Self-Expanding Metal Stents in Patients with Cirrhosis and Severe or Refractory Esophagealvariceal Bleeding: A Systematic Review and Meta-Analysis (2016) (0)
- HBV-HCV Coinfection: Insights from a Novel Model System (2008) (0)
- Akute und chronische Hepatitis E (2017) (0)
- Randomisierte, kontrollierte Studie zur Wirksamkeit von PegIFN-alpha 2a + Plasmaspiegel-adaptiertem Ribavirin vs. PegIFN-alpha 2a + gewichts-basiertem Ribavirin bei chronischer Hepatitis C Genotyp 1 (2011) (0)
- Therapie der Hepatitis C (2002) (0)
- Molekularbiologie in der Inneren Medizin: Bericht über das 24.Ludwig-Heilmeyer-Symposium der Gesellschaft für Fortschritte in der Inneren Medizin (2008) (0)
- Hepatitis C: Information für Patienten (2015) (0)
- Von der molekularen Medizin bis zur Naturheilkunde (2018) (0)
- [Chronic hepatitis. 1: Diagnosis]. (2001) (0)
- Neues aus der Hepatologie (2011) (0)
- [Hepatitis C]. (2004) (0)
- Hepatitis-C-Therapie bei Drogenpatienten - Replik (2005) (0)
- [Chronic hepatitis. 3. An actual case]. (2001) (0)
- Pilotstudie zur Bedeutung von Mutationen der Hepatitis C Virus 1b “Interferon Sensitivity Determining Region” (NS5A aa 2209–2248) für das Ansprechen auf Interferon-α bei Patienten mit chronischer Hepatitis (1999) (0)
- Molekulare Krankheitsmodelle – Transgene und «knockout» (2009) (0)
- Oesophagite a eosinophiles: mise a jour 2011. (2011) (0)
- ER Folgen des Alkohols (2002) (0)
- Effiziente MAVS-Spaltung und Suppression der Interferon-β-Induktion durch HCV-Varianten mit Resistenzen gegen makrozyklische NS3-4A Protease-Inhibitoren (2014) (0)
- [Eosinophilic esophagitis: update 2011]. (2011) (0)
- Hepatologie: Wichtiges zur chronischen Hepatitis C (2013) (0)
- Hauptthema: Benigne und maligne Gallenwegstenosen (1999) (0)
- [Viral hepatitis]. (2011) (0)
- A picture says more than a thousand words: Structural insights into hepatitis C virus translation initiation (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Darius Moradpour?
Darius Moradpour is affiliated with the following schools: